Retatrutide vs Ozempic: Is the Triple Agonist Worth It?
Retatrutide is the next generation beyond Ozempic — a triple agonist targeting GLP-1, GIP, and glucagon receptors. Phase 2 data shows ~24% weight loss vs ~15% for semaglutide. Here's what the research says.
The Short Answer
Retatrutide produces greater weight loss than Ozempic, but has less clinical data. Phase 2 trials show ~24% weight loss at 48 weeks vs ~15% for semaglutide at 68 weeks. The trade-off: retatrutide has only Phase 2 data and higher GI side effect rates. For researchers who want maximum fat loss and are comfortable with Phase 2-level evidence, retatrutide is the most potent option available.
Pathway Comparison Diagram
Retatrutide activates three receptors (GLP-1R + GIPR + GcgR) for ~24% weight loss; Ozempic activates GLP-1R only for ~15% — the two additional receptors explain the clinical gap.
Research use only. Compound Review scores vendors on documentation — laboratory certificates, lot records, pricing and company identity. Nothing on this page is guidance on human or veterinary use, dosing or health outcomes.
Head-to-Head Comparison
| Feature | Semaglutide (Ozempic) | Retatrutide |
|---|---|---|
| Mechanism | GLP-1 agonist | GLP-1 + GIP + Glucagon triple agonist |
| Mean weight loss | ~15% (STEP 1, 68 wks) | ~24% (Phase 2, 48 wks) |
| Thermogenic effect | No | Yes (glucagon receptor) |
| Visceral fat reduction | Moderate | Strongest studied to date |
| FDA approval status | Yes (Ozempic/Wegovy) | Phase 3 (not yet approved) |
| Cardiovascular data | Yes (FLOW trial) | Not yet available |
| Nausea rate | 30–44% | 47–58% (higher) |
| Half-life | ~7 days | ~6 days |
| Research grade available | Yes (Purgo Labs) | Yes (Purgo Labs) |
When to Choose Each Compound
Choose Semaglutide (Ozempic) if…
- You want the most published safety data
- Cardiovascular outcomes are a research priority
- You prefer the most established titration protocol
- Lower GI side effect rates are important
Choose Retatrutide if…
- Maximum weight loss is the primary research goal
- Thermogenesis and energy expenditure are of interest
- You're comfortable with Phase 2-level evidence
- Visceral fat reduction is a key endpoint
Frequently Asked Questions
Is retatrutide better than Ozempic?
Clinical trial data shows retatrutide produces greater weight loss than semaglutide (Ozempic). Phase 2 trials showed retatrutide produced ~24% mean weight loss at 48 weeks, compared to ~15% for semaglutide at 68 weeks. However, retatrutide has only Phase 2 data — semaglutide has extensive Phase 3 trials and cardiovascular outcome data. For research purposes, retatrutide represents the next generation of GLP-based compounds.
What is the difference between retatrutide and Ozempic?
Ozempic (semaglutide) is a GLP-1 receptor agonist. Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. The additional glucagon receptor agonism increases thermogenesis and energy expenditure beyond what GLP-1 alone achieves, resulting in greater fat loss.
Is retatrutide FDA approved?
No. Retatrutide completed Phase 2 trials with strong results and is currently in Phase 3 trials. It is not FDA approved for any indication. Semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) are the only GLP-class compounds with FDA approval. Research-grade retatrutide is available for research purposes only.
What are the side effects of retatrutide compared to Ozempic?
Retatrutide has higher rates of nausea and vomiting than semaglutide — approximately 47–58% nausea at therapeutic doses vs 30–44% for semaglutide. This is attributed to the additional glucagon receptor agonism. Both share the same class-level GI side effect profile, and both improve with slow titration.
Where can I buy research-grade retatrutide?
Purgo Labs carries research-grade retatrutide with third-party COAs confirming purity. All compounds are sold for research purposes only. Code HEALTH is 20% off every order at Purgo Labs (verified recurring).
Source Research-Grade Retatrutide
Purgo Labs provides research-grade retatrutide with third-party COAs. Code HEALTH is 20% off every order at Purgo Labs (verified recurring).
Buy Retatrutide at Purgo Labs